CancerPartnersUK is the UK’s first network of high quality, specialist outpatient cancer centres. The company was founded by Apposite Capital and an experienced management team based on well-established operating models developed outside the UK.


The company is committed to providing best clinical practice, using the latest radiotherapy technologies and techniques (eg IMRT, IGRT, Breath hold, VMAT) for a more precise and accurate treatment, and focusing on delivering the best possible patient experience.

Key Developments

Over the course of Apposite’s investment, CancerPartnersUK successfully expanded its geographical footprint, with the opening of eight state-of-the-art cancer centres outside London. The company initially focused on providing superior radiotherapy services to cancer patients before expanding its offering to chemotherapy and diagnostic services. Apposite helped build up the management team. The company employed c160 people at the time of exit. The company was ranked 33rd in the Sunday Times fast track 100 (December 2013).

CancerPartnersUK was acquired by GenesisCare in July 2015.